ERBB2 and neoplasm: In line with these findings, histological evaluation of tumor-bearing tibias at sacrifice (Figure 4E) demonstrated a smaller trabecular bone area (Figure 4F) and total tumor area (Figure 4G) in the HER2-TTC-treated mice compared to the vehicle-treated control group.